Dose-Finding Study of Bixalomer in Patients With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia: A Double-Blind, Randomized, Placebo-Controlled and Sevelamer Hydrochloride-Controlled Open-Label, Parallel Group Study

Author:

Akizawa Tadao1,Origasa Hideki2,Kameoka Chisato3,Kaneko Yuichiro3,Kanoh Hiroyuki3

Affiliation:

1. Division of Nephrology, Department of Medicine; Showa University School of Medicine; Toyama Japan

2. Division of Biostatistics and Clinical Epidemiology; University of Toyama School of Medicine; Toyama Japan

3. Astellas Pharma Inc.; Tokyo Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Reference18 articles.

1. Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study;Block;Am J Kidney Dis,1998

2. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis;Block;J Am Soc Nephrol,2004

3. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients;Noordzij;Nephrol Dial Transplant,2011

4. Association of elevated serum PO (4), Ca×PO (4)product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients;Ganesh;J Am Soc Nephrol,2001

5. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Pattern Study;Young;Kidney Int,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3